Tocilizumab achieved a ≥50% seizure reduction in 63% of pediatric FIRES patients during the chronic phase!
Explore
What is the efficacy & safety of the interleukin-6 receptor inhibitors #tocilizumab and #satralizumab in #MOGAD?
Aasim Ali & colleagues conducted a #SystematicReview and #MetaAnalysis to summarize the evidence:
journals.sagepub.com/doi/full/10....
